These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 24323469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens.
    Montgomery AB, Rhomberg PR, Abuan T, Walters KA, Flamm RK.
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3714-9. PubMed ID: 24752275
    [Abstract] [Full Text] [Related]

  • 4. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex.
    García-Fernández S, Bala Y, Armstrong T, García-Castillo M, Burnham CA, Wallace MA, Hardy D, Zambardi G, Cantón R.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31597745
    [Abstract] [Full Text] [Related]

  • 5. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study.
    Bielen L, Likić R, Erdeljić V, Mareković I, Firis N, Grgić-Medić M, Godan A, Tomić I, Hunjak B, Markotić A, Bejuk D, Tičić V, Balzar S, Bedenić B.
    Croat Med J; 2018 Apr 30; 59(2):56-64. PubMed ID: 29740989
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.
    Flamm RK, Rhomberg PR, Lindley JM, Sweeney K, Ellis-Grosse EJ, Shortridge D.
    Antimicrob Agents Chemother; 2019 May 30; 63(5):. PubMed ID: 30858207
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF.
    J Med Microbiol; 2017 Jan 30; 66(1):61-69. PubMed ID: 28051952
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T, Buyukguclu T.
    Int J Infect Dis; 2013 Nov 30; 17(11):e966-70. PubMed ID: 23742831
    [Abstract] [Full Text] [Related]

  • 9. The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.
    Williams PCM, Waichungo J, Gordon NC, Sharland M, Murunga S, Kamau A, Berkley JA.
    J Med Microbiol; 2019 May 30; 68(5):711-719. PubMed ID: 30994430
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program).
    Lob SH, Hackel MA, Kazmierczak KM, Young K, Motyl MR, Karlowsky JA, Sahm DF.
    Antimicrob Agents Chemother; 2017 Jun 30; 61(6):. PubMed ID: 28320716
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
    Rizek C, Ferraz JR, van der Heijden IM, Giudice M, Mostachio AK, Paez J, Carrilho C, Levin AS, Costa SF.
    J Infect Chemother; 2015 Feb 30; 21(2):114-7. PubMed ID: 25456893
    [Abstract] [Full Text] [Related]

  • 12. Polymyxin B Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICs.
    Kulengowski B, Ribes JA, Burgess DS.
    Clin Microbiol Infect; 2019 Jan 30; 25(1):92-95. PubMed ID: 29674129
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
    Karlowsky JA, Lob SH, Kazmierczak KM, Hawser SP, Magnet S, Young K, Motyl MR, Sahm DF.
    J Antimicrob Chemother; 2018 Jul 01; 73(7):1872-1879. PubMed ID: 29659861
    [Abstract] [Full Text] [Related]

  • 14. Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
    Rajenderan S, Balaji V, Anandan S, Sahni RD, Tansarli GS, Falagas ME.
    PLoS One; 2014 Jul 01; 9(7):e103253. PubMed ID: 25068396
    [Abstract] [Full Text] [Related]

  • 15. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
    Mojica MF, De La Cadena E, Hernández-Gómez C, Correa A, Appel TM, Pallares CJ, Villegas MV.
    J Glob Antimicrob Resist; 2020 Jun 01; 21():391-395. PubMed ID: 32004722
    [Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH.
    Antimicrob Agents Chemother; 2007 Oct 01; 51(10):3726-30. PubMed ID: 17646414
    [Abstract] [Full Text] [Related]

  • 17. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.
    Kaase M, Szabados F, Anders A, Gatermann SG.
    J Clin Microbiol; 2014 Jun 01; 52(6):1893-7. PubMed ID: 24648559
    [Abstract] [Full Text] [Related]

  • 18. The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.
    Elliott ZS, Barry KE, Cox HL, Stoesser N, Carroll J, Vegesana K, Kotay S, Sheppard AE, Wailan A, Crook DW, Parikh H, Mathers AJ.
    J Clin Microbiol; 2019 Oct 01; 57(10):. PubMed ID: 31340992
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
    Mahmoudi S, Mahzari M, Banar M, Pourakbari B, Haghi Ashtiani MT, Mohammadi M, Keshavarz Valian S, Mamishi S.
    J Glob Antimicrob Resist; 2017 Dec 01; 11():17-22. PubMed ID: 28729206
    [Abstract] [Full Text] [Related]

  • 20. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P, Hasçelik G, Unal S.
    Mikrobiyol Bul; 2006 Jul 01; 40(3):147-54. PubMed ID: 17001842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.